Diniz-Freitas
M, Limeres J. Prevention of
medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Mar 1;21
(2):e250-9.
doi:10.4317/medoral.20963
http://dx.doi.org/doi:10.4317/medoral.20963
|
1. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T,
Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons
position paper on medication-related osteonecrosis of the jaw-2014 update. J
Oral Maxillofac Surg. 2014;72:1938-56. |
|
|
|
|
|
2. Kuhl S, Walter C, Acham S, Pfeffer R, Lambrecht JT.
Bisphosphonate-related osteonecrosis of the jaws--a review. Oral Oncol.
2012;48:938-47. |
|
|
|
|
|
3. Diniz-Freitas M, Lopez-Cedrun JL, Fernandez-Sanroman J,
Garcia-Garcia A, Fernandez-Feijoo J, Diz-Dios P. Oral bisphosphonate-related
osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases
in Spain. Med Oral Patol Oral Cir Bucal. 2012;17:e751-8. |
|
|
|
|
|
4. Bagan J, Scully C, Sabater V, Jimenez Y. Osteonecrosis of the
jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise
update. Oral Oncol. 2009;45:551-4. |
|
|
|
|
|
5. Montefusco V, Gay F, Spina F, Miceli R, Maniezzo M, Teresa
Ambrosini M, et al. Antibiotic prophylaxis before dental procedures may
reduce the incidence of osteonecrosis of the jaw in patients with multiple
myeloma treated with bisphosphonates. Leuk Lymphoma. 2008;49:2156-62. |
|
|
|
|
|
6. American Association of Oral and Maxillofacial Surgeons.
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws,
American Association of Oral and Maxillofacial Surgeons position paper on
bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg.
2007;65:369-76. |
|
|
|
|
|
7. Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A,
Migliorati CA, et al. Updated recommendations for managing the care of
patients receiving oral bisphosphonate therapy: an advisory statement from
the American Dental Association Council on Scientific Affairs. J Am Dent
Assoc. 2008;139:1674-7. |
|
|
|
|
|
8. Bagan J, Blade J, Cozar JM, Constela M, Garcia Sanz R, Gomez
Veiga F, et al. Recommendations for the prevention, diagnosis, and treatment
of osteonecrosis of the jaw (ONJ) in cancer patients treated with
bisphosphonates. Med Oral Patol Oral Cir Bucal. 2007;12:E336-40. |
|
|
|
|
|
9. Tubiana-Hulin M, Spielmann M, Roux C, Campone M, Zelek L,
Gligorov J, et al. Physiopathology and management of osteonecrosis of the
jaws related to bisphosphonate therapy for malignant bone lesions. A French
expert panel analysis. Crit Rev Oncol Hematol. 2009;71:12-21. |
|
|
|
|
|
10. Bennani A, Rerhrhaye W, Soualhi H, El Wady W. Non traumatic
tooth extraction in patients treated by bisphosphonate. Rev Stomatol Chir
Maxillofac. 2008;109:405-7. |
|
|
|
|
|
11. Hoefert S, Grimm M, Sharghi F, Geist A, Krimmel M, Reinert
S. Atraumatic tooth extraction in patients taking bisphosphonates: a review
of literature and experience with three cases. Oral Maxillofac Surg. 2014;18:341-9. |
|
|
|
|
|
12. Agrillo A, Sassano P, Rinna C, Priore P, Iannetti G. Ozone
therapy in extractive surgery on patients treated with bisphosphonates. J
Craniofac Surg. 2007;18:1068-70. |
|
|
|
|
|
13. Hellstein JW, Adler RA, Edwards B, Jacobsen PL, Kalmar JR,
Koka S, et al., American Dental Association Council on Scientific Affairs
Expert Panel on Antiresorptive Agents. Managing the care of patients
receiving antiresorptive therapy for prevention and treatment of
osteoporosis: executive summary of recommendations from the American Dental
Association Council on Scientific Affairs. J Am Dent Assoc. 2011;142:1243-51. |
|
|
|
|
|
14. Sambrook P, Olver I, Goss A. Bisphosphonates and
osteonecrosis of the jaw. Aust Fam Physician. 2006;35:801-3. |
|
|
|
|
|
15. Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M, Amin F,
et al., Canadian Taskforce on Osteonecrosis of the Jaw. Bisphosphonate
associated osteonecrosis of the jaw. J Rheumatol. 2009;36:478-90. |
|
|
|
|
|
16. American Dental Association Council on Scientific Affairs.
Dental management of patients receiving oral bisphosphonate therapy: expert
panel recommendations. J Am Dent Assoc. 2006;137:1144-50. |
|
|
|
|
|
17. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR,
Felsenberg D, et al, American Society for Bone and Mineral Research.
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of
the American Society for Bone and Mineral Research. J Bone Miner Res.
2007;22:1479-91. |
|
|
|
|
|
18. Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D,
Hadjii P. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer
patients: recommendations for prevention and treatment. Breast.
2009;18:213-7. |
|
|
|
|
|
19. Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S,
et al. Bisphosphonate-related osteonecrosis of the jaw: position paper from
the Allied Task Force Committee of Japanese Society for Bone and Mineral
Research, Japan Osteoporosis Society, Japanese Society of Periodontology,
Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society
of Oral and Maxillofacial Surgeons. J Bone Miner Metab. 2010;28:365-83. |
|
|
|
|
|
20. Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK,
O'Ryan F, et al, International Task Force on Osteonecrosis of the Jaw.
Diagnosis and management of osteonecrosis of the jaw: a systematic review and
international consensus. J Bone Miner Res. 2015;30:3-23. |
|
|
|
|
|
21. Fedele S, Kumar N, Davies R, Fiske J, Greening S, Porter S.
Dental management of patients at risk of osteochemonecrosis of the jaws: a
critical review. Oral Dis. 2009;15:527-37. |
|
|
|
|
|
22. Urrtia G, Bonfill X. [PRISMA declaration: a proposal to
improve the publication of systematic reviews and meta-analyses]. Med Clin
(Barc). 2010;135:507-11. |
|
|
|
|
|
23. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi
A. Tooth extraction in patients taking intravenous bisphosphonates: a
preventive protocol and case series. J Oral Maxillofac Surg. 2010;68:107-10. |
|
|
|
|
|
24. Saia G, Blandamura S, Bettini G, Tronchet A, Totola A,
Bedogni G, et al. Occurrence of bisphosphonate-related osteonecrosis of the
jaw after surgical tooth extraction. J Oral Maxillofac Surg. 2010;68:797-804. |
|
|
|
|
|
25. Ferlito S, Puzzo S, Liardo C. Preventive protocol for tooth
extractions in patients treated with zoledronate: a case series. J Oral
Maxillofac Surg. 2011;69:e1-4. |
|
|
|
|
|
26. Schubert M, Klatte I, Linek W, Muller B, Doring K, Eckelt U,
et al. The saxon bisphosphonate register - therapy and prevention of
bisphosphonate-related osteonecrosis of the jaws. Oral Oncol. 2012;48:349-54. |
|
|
|
|
|
27. Taylor T, Bryant C, Popat S. A study of 225 patients on
bisphosphonates presenting to the bisphosphonate clinic at King's College
Hospital. Br Dent J. 2013;214:E18. |
|
|
|
|
|
28. Sanchis JM, Bagan JV, Murillo J, Diaz JM, Asensio L. Risk of
developing BRONJ among patients exposed to intravenous bisphosphonates
following tooth extraction. Quintessence Int. 2014;45:769-77. |
|
|
|
|
|
29. Kato GF, Lopes RN, Jaguar GC, Silva AP, Alves FA. Evaluation
of socket healing in patients undergoing bisphosphonate therapy: experience
of a single Institution. Med Oral Patol Oral Cir Bucal. 2013;18:e650-6. |
|
|
|
|
|
30. Lopez-Jornet P, Camacho-Alonso F, Martinez-Canovas A,
Molina-Minano F, Gomez-Garcia F, Vicente-Ortega V. Perioperative antibiotic
regimen in rats treated with pamidronate plus dexamethasone and subjected to
dental extraction: a study of the changes in the jaws. J Oral Maxillofac
Surg. 2011;69:2488-93. |
|
|
|
|
|
31. Mozzati M, Arata V, Gallesio G. Tooth extraction in patients
on zoledronic acid therapy. Oral Oncol. 2012;48:817-21. |
|
|
|
|
|
32. Scoletta M, Arduino PG, Pol R, Arata V, Silvestri S,
Chiecchio A, et al. Initial experience on the outcome of teeth extractions in
intravenous bisphosphonate-treated patients: a cautionary report. J Oral
Maxillofac Surg. 2011;69:456-62. |
|
|
|
|
|
33. Scoletta M, Arata V, Arduino PG, Lerda E, Chiecchio A,
Gallesio G, et al. Tooth extractions in intravenous bisphosphonate-treated
patients: a refined protocol. J Oral Maxillofac Surg. 2013;71:994-9. |
|
|
|
|
|
34. Del Fabbro M, Gallesio G, Mozzati M. Autologous platelet
concentrates for bisphosphonate-related osteonecrosis of the jaw treatment
and prevention. A systematic review of the literature. Eur J Cancer.
2015;51:62-74. |
|
|
|
|
|
35. Vescovi P, Meleti M, Merigo E, Manfredi M, Fornaini C,
Guidotti R, et al. Case series of 589 tooth extractions in patients under
bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG
low-level laser therapy. Med Oral Patol Oral Cir Bucal. 2013;18:e680-5. |
|
|
|
|
|
36. Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena
D, et al. Risk factors for osteonecrosis of the jaws: a case-control study
from the CONDOR dental PBRN. J Dent Res. 2011;90:439-44. |
|
|
|
|
|
37. Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A,
et al. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not
just a sporadic coincidence--a multi-centre study. J Craniomaxillofac Surg.
2011;39:272-7. |
|
|
|
|
|
38. Mozzati M, Arata V, Gallesio G. Tooth extraction in
osteoporotic patients taking oral bisphosphonates. Osteoporos Int.
2013;24:1707-12. |
|
|
|
|
|
39. Hasegawa T, Ri S, Umeda M, Komatsubara H, Kobayashi M,
Shigeta T, et al. The observational study of delayed wound healing after
tooth extraction in patients receiving oral bisphosphonate therapy. J
Craniomaxillofac Surg. 2013;41:558-63. |
|
|
|
|
|
40. Diniz-Freitas M, Fernandez-Feijoo J, Fernandez-Montenegro P,
Gonzalez-Mosquera A, Vazquez-Garcia E, Diz-Dios P. Criteria for the
prescription of oral bisphosphonates for the treatment of osteoporosis in a
series of women referred for tooth extraction. Med Oral Patol Oral Cir Bucal.
2012;17:e601-4. |
|
|
|
|